HTG Molecular Diagnostics Inc (HTGMQ)
0.0025
0.00 (0.00%)
USD |
OTCM |
Apr 26, 16:00
HTG Molecular Diagnostics Gross Profit Margin (Quarterly)
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2023 | -11.34% |
| December 31, 2022 | 16.71% |
| September 30, 2022 | 46.37% |
| June 30, 2022 | 31.99% |
| March 31, 2022 | 27.81% |
| December 31, 2021 | 52.90% |
| September 30, 2021 | 60.97% |
| June 30, 2021 | 53.18% |
| March 31, 2021 | 45.29% |
| December 31, 2020 | 58.94% |
| September 30, 2020 | 47.05% |
| June 30, 2020 | 50.36% |
| March 31, 2020 | 54.37% |
| December 31, 2019 | 70.45% |
| September 30, 2019 | 45.62% |
| June 30, 2019 | 56.72% |
| March 31, 2019 | 36.13% |
| December 31, 2018 | 83.66% |
| September 30, 2018 | 73.66% |
| Date | Value |
|---|---|
| June 30, 2018 | 70.46% |
| March 31, 2018 | 72.66% |
| December 31, 2017 | 82.91% |
| September 30, 2017 | 70.75% |
| June 30, 2017 | 29.75% |
| March 31, 2017 | 5.53% |
| December 31, 2016 | 15.32% |
| September 30, 2016 | -23.10% |
| June 30, 2016 | 50.79% |
| March 31, 2016 | 2.52% |
| December 31, 2015 | 34.45% |
| September 30, 2015 | 19.98% |
| June 30, 2015 | -5.62% |
| March 31, 2015 | 12.66% |
| December 31, 2014 | 7.56% |
| September 30, 2014 | 14.12% |
| June 30, 2014 | -84.08% |
| March 31, 2014 | 22.28% |
| December 31, 2013 | -14.37% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
-11.34%
Minimum
Mar 2023
70.45%
Maximum
Dec 2019
44.21%
Average
48.71%
Median
Gross Profit Margin (Quarterly) Benchmarks
| Viveve Medical Inc | -- |
| Minerva Surgical Inc | 51.97% |
| Stereotaxis Inc | 59.98% |
| Electromed Inc | 77.03% |
| Myomo Inc | 65.28% |